COGT
Cogent Biosciences
$30.91
−$0.30 (−0.96%)Oct 26, 2026
Key metrics
The numbers that frame COGT today
- Market cap
- $5.36B
- ROIC
- -53.6%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $13.78
- 52wk High
- $43.73
Growth
Revenue and earnings trend for COGT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about COGT
Is Cogent Biosciences a good buy?
Hold. Cogent Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Cogent Biosciences is selling at a high price.
What is the market capitalization of COGT?
Cogent Biosciences's market capitalization is $5.36B.
What is the 52-week high for COGT stock?
The 52-week high for Cogent Biosciences is $43.73. The current close of $30.91 is 29.3% below that high.
What is the 52-week low for COGT stock?
The 52-week low for Cogent Biosciences is $13.78. The current close of $30.91 is 124.3% above that low.
Does COGT stock pay dividends?
Cogent Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for COGT?
Cogent Biosciences's Debt / Equity ratio is 0.46.